Tiopronin: Clinical Trials

4 trials of Tiopronin, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed. 3 Phase 2, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 23Completed 3
Phase 41Completed 1

Follow Tiopronin: new trials by email Literature Review of Tiopronin trials Research Report on Tiopronin

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effect of Increasing Doses of Tiopronin on Cystine Capacity in Patients With Cystinuria
Tiopronin - Cystinuria
Phase 2CompletedNYU Langone Health102018-11-012021-12-17
Effect of Increasing Doses of Cystine Binding Thiol Drugs on Cystine Capacity in Patients With Cystinuria
Tiopronin 1g per day, Tiopronin 2g per day, Tiopronin 3g per day - Cystinuria
Phase 4CompletedNYU Langone Health102012-06-012021-08-23
The Effects of Tiopronin on 3-Aminopropanal Level & Neurologic Outcome After Aneurysmal Subarachnoid Hemorrhage
Tiopronin, Placebo - Aneurysmal Subarachnoid Hemorrhage
Phase 2CompletedE. Sander Connolly602010-04-012025-10-29
Efficacy and Safety Study of Magnesium Isoglycyrrhizinate Injection in Subjects With Acute Drug-induced Liver Injury
Magnesium Isoglycyrrhizinate Injection 100mg OD, Magnesium Isoglycyrrhizinate Injection 200mg OD, Tiopronin Injection - Drug-Induced Liver Injury
Phase 2CompletedChia Tai Tianqing Pharmaceutical Group Co., Ltd.1742007-12-012016-09-27

Conditions studied

Cystinuria (2)  ·  Aneurysm (1)  ·  Brain Ischemia (1)  ·  Chemical and Drug Induced Liver Injury (1)  ·  Hemorrhage (1)  ·  Subarachnoid Hemorrhage (1)

Sponsors

NYU Langone Health (2)  ·  Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (1)  ·  E. Sander Connolly (1)

Countries

United States (3)  ·  China (1)

Top investigators

Brian Hoh, M.D. (1)  ·  David Goldfarb, MD (1)  ·  David S Goldfarb, MD (1)  ·  E Sander Connolly, M.D. (1)  ·  Louis Kim, M.D. (1)  ·  Minde Zeng, MD (1)

Results publications

PMID 31299655

NIH funding

U54DK083908 (1)